Ratings Balaji Amines Limited NSE India S.E.

Equities

BALAMINES

INE050E01027

Market Closed - NSE India S.E. Other stock markets 07:43:47 2024-05-03 am EDT			5-day change	1st Jan Change
2,153 ^INR	-1.02%		-3.06%	-19.30%

Mar. 14	India Ratings Keeps Balaji Amines Rating at AA; Outlook Stable	MT
Jan. 31	Balaji Amines Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

The group's high margin levels account for strong profits.
Analysts covering this company mostly recommend stock overweighting or purchase.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Over the past four months, analysts' average price target has been revised upwards significantly.
The opinion of analysts covering the stock has improved over the past four months.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
With an expected P/E ratio at 34.46 and 23.53 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last few months, analysts have been revising downwards their earnings forecast.
Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
BALAJI AMINES LIMITED	-19.30%	837M	-
ECOLAB INC.	+14.70%	65.04B	A-
SIKA AG	-1.61%	47.76B	A-
GIVAUDAN SA	+14.58%	40.72B	B+
FUJIFILM HOLDINGS CORPORATION	+20.84%	26.88B	A-
CELANESE CORPORATION	+1.16%	17.53B	B+
POSCO FUTURE M CO., LTD.	-21.87%	16.03B	A-
SYMRISE AG	+1.11%	15.17B	B+
ALBEMARLE CORPORATION	-11.34%	15.06B	C+
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-20.82%	13.62B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes